Therapeutic applications of nanobots and nanocarriers in cancer treatment

Related Experiment Video

Updated: Sep 19, 2025

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.0K

Zaitoon Khan1, Nimra Khan1, Mithra Geetha1

  • 1Center for Advanced Materials, Qatar University, Doha, Qatar.

Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry
|June 4, 2025
PubMed

Insights

Nanotechnology, using nanobots and nanocarriers, offers advanced cancer treatment by enabling precise drug delivery and reducing side effects. These innovations aim to improve therapeutic efficacy and pave the way for clinical applications in precision medicine.

Area of Science:

  • Nanomedicine
  • Biotechnology
  • Oncology

Background:

  • Cancer presents a significant global health challenge with limited therapeutic options.
  • Nanotechnology is emerging as a transformative approach in cancer research and treatment.
  • Nanobots and nanocarriers are key nanotechnology components revolutionizing cancer therapy.

Purpose of the Study:

  • To review the potential of nanobots and nanocarriers in cancer treatment.
  • To highlight their role in advancing precision medicine and targeted drug delivery.
  • To provide insights into their transition from laboratory research to clinical applications.

Main Methods:

  • Review of current research on nanobots and nanocarriers in cancer therapy.
  • Analysis of their size, biocompatibility, and drug delivery capabilities.
  • Examination of their potential to enhance diagnostics and disease prevention at molecular levels.

Main Results:

  • Nanobots and nanocarriers (1-100 nm) offer precise drug delivery and reduced side effects compared to conventional therapies.
  • They demonstrate biocompatibility with cellular systems.
  • Current research focuses on their clinical translation for improved cancer outcomes.

Conclusions:

  • Nanobots and nanocarriers hold significant promise for revolutionizing cancer therapy.
  • Their precise drug delivery and reduced toxicity are key advantages.
  • Further research and clinical translation are crucial for realizing their full potential in improving patient outcomes.
Keywords:
Cancer treatmentDrug deliveryNano-formulationNanobotsNanocarriers

More Related Videos

Manufacture and Drug Delivery Applications of Silk Nanoparticles09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.0K
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.2K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
522